Prevalence of thyroid dysfunction in untreated cancer patients: A cross-sectional study

Medical Oncology

Volumn 29, Issue 5, 2012, Pages 3608-3613

  Dişel, Umut ^a   Beşen, Ayberk ^a   Karadeniz, Cemile ^a   Mertsoylu, Hüseyin ^a   Sezer, Ahmet ^a   Köse, Fatih ^a   Tanersümbül, Ahmet ^a   Gürkut, Özlem ^b   Muallaoǧlu, Sadik ^a   Abali, Hüseyin ^a   Özyilkan, Özgür ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b NEAR EAST UNIVERSITY   (Turkey)

Author keywords

Cancer; Euthyroid sick syndrome; Hyperthyroidism; Hypothyroidism; Thyroid dysfunction

Indexed keywords

THYROID HORMONE;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIGESTIVE SYSTEM CANCER; EUTHYROID SICK SYNDROME; EUTHYROIDISM; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; INFANT; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SUBCLINICAL HYPERTHYROIDISM; SUBCLINICAL HYPOTHYROIDISM; THYROID DISEASE; THYROID FUNCTION TEST; THYROID HORMONE METABOLISM; HISTORY; MIDDLE AGED; NEWBORN; PREVALENCE;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FEMALE; HISTORY, ANCIENT; HUMANS; INFANT, NEWBORN; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; THYROID DISEASES; THYROID FUNCTION TESTS; YOUNG ADULT;

EID: 84879256471     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-012-0254-4     Document Type: Article

References (19)

1. Shani D, Brand DA, Patrick PA. Unrecognized thyroid dysfunction in patients with cancer. Support Care Cancer. 2003;11(1):63-5. Epub 2002 Dec 18.
2. Ladenson PW, Singer PA, Ain KB, et al. American thyroid association guidelines for detection of thyroid dysfunction. Arch Int Med. 2000;160:1573-6.
3. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87:489-99.
4. Emral R, Baştemir M, Erdoǧan G, Güllü S. High prevalence of thyroid dysfunction and autoimmune thyroiditis in adolescents after elimination of Iodine deficiency in Eastern Black Sea Region of Turkey. Turk J Endocrinol Metab. 2006;1:13-20.
5. US Preventive Services Task Force. Screening for thyroid disease. In: Guide to clinical preventive services. 2nd edn. 1996; 209. Baltimore: Williams & Wilkins.
6. Helfand M, Redfern CC. Screening for thyroid disease: an update. Ann Intern Med. 1998;129:144-58.
7. Hage M, Zantout MS, Azar ST. Thyroid disorders and diabetes mellitus. J Thyroid Res. 2011;2011:439-63.
8. Maheshwari A, Thuluvath PJ. Endocrine diseases and the liver. Clin Liver Dis. 2011;15(1):55-67. (Review).
9. Wilson C. Thyroid function: new guidance for the diagnosis and management of thyroid diseases in pregnancy. Nat Rev Endocrinol. 2011.
10. Ratcliffe JG, Stack BH, Burt RW, et al. Thyroid function in lung cancer. Br Med J. 1978;1(6107):210-2.
11. Tellini U, Pellizzari L, Pravadelli B. Thyroid function in elderly with neoplasms, Minerva Med. 1999; 90(4):111-21.
12. Cristofanilli M, Yamamura Y, Kau SW, Bevers T, et al. Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma. Cancer. 2005;103(6):1122-8.
13. Turken O, Narin Y, DemIrbas S, et al. Breast cancer in association with thyroid disorders. Breast Cancer Res. 2003;5(5):R110-3.
14. Moskowitz C, Dutcher JP, Wiernik PH. Association of thyroid disease with acute leukemia. Am J Hematol. 1992;39(2):102-7.
15. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease. Scientific review and guidelines for diagnosis and management. JAMA. 2004;291:228-38.
16. McIver B, Gorman CA. Euthyroid sick syndrome: an overview. Thyroid. 1997;7(1):125-32.
17. Tognini S, Marchini F, Dardano A, et al. Non-thyroidal illness syndrome and short-term survival in a hospitalised older population. Age Ageing. 2010;39(1):46-50.
18. Torino F, Corsello SM, Longo R, Barnabei A, Gasparini G. Hypothyroidism related to tyrosine kinase inhibitors: an emerging toxic effect of targeted therapy. Nat Rev Clin Oncol. 2009;6(4):219-28.
19. Sabatier R, Eymard JC, Walz J et al. Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma? Ann Oncol. 2011.